NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 5 filers reported holding NLS PHARMACEUTICS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $134,000 | – | 33,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 10,607 | $12,000 | 0.00% |
| UBS Group AG | 12,772 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 45,879 | $51,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,362 | $16,000 | 0.00% |
| Renaissance Technologies | 10,800 | $12,000 | 0.00% |
| HRT FINANCIAL LP | 14,028 | $15,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 22,800 | $25,000 | 0.00% |